Alector ALEC
NASDAQ ALEC
$2.46 -0.05 (-1.99%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alector (ALEC) Common Equity (2018 - 2026)

Alector's (ALEC) quarterly Common Equity came in at -$10.0 million in Q2 2026, down 114.01% year-over-year from $71.2 million in Q2 2025, and down 196.03% quarter-over-quarter from $10.4 million in Q1 2026.

Analysis

Alector (ALEC) Common Equity (2018 - 2026) Analysis & Trends

Alector (ALEC) has reported Common Equity for 9 consecutive years, with -$10.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Common Equity fell 114.01% year-over-year to -$10.0 million in Q2 2026; TTM through Jun 2026 was -$10.0 million, a 114.01% decrease from a year earlier, with the FY2025 full-year figure at $30.6 million, down 75.83% from the prior year.
  • Common Equity was -$10.0 million for Q2 2026 at Alector, down from $10.4 million in the prior quarter.
  • Over five years, Common Equity peaked at $288.5 million in Q2 2022 and troughed at -$10.0 million in Q2 2026.
  • A 5-year average of $140.5 million and a median of $142.4 million in 2023 frame the typical range for Common Equity.
  • Across the five-year window, Common Equity jumped 56.36% in 2022 and plunged 114.01% in 2026, its largest moves.
  • Over 5 years, Common Equity stood at $214.4 million in 2022, then tumbled by 37.44% to $134.2 million in 2023, then retreated by 5.48% to $126.8 million in 2024, then sank by 75.83% to $30.6 million in 2025, then tumbled by 132.53% to -$10.0 million in 2026.
  • The last three Common Equity figures came in at -$10.0 million (Q2 2026), $10.4 million (Q1 2026), and $30.6 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 11.69 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 11.83 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 20.25 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 31.71 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn 8.42 Bn
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 6.76 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 1.35 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 18.85 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 757.49 Mn
10 Alector 274.68 Mn 101.88 Mn - -9.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.97 Mn
Mar 31, 2026 10.38 Mn
Dec 31, 2025 30.65 Mn
Sep 30, 2025 57.71 Mn
Jun 30, 2025 71.18 Mn
Mar 31, 2025 94.61 Mn
Dec 31, 2024 126.80 Mn
Sep 30, 2024 118.93 Mn
Jun 30, 2024 150.57 Mn
Mar 31, 2024 178.91 Mn
Dec 31, 2023 134.16 Mn
Sep 30, 2023 162.56 Mn
Jun 30, 2023 196.31 Mn
Mar 31, 2023 183.02 Mn
Dec 31, 2022 214.44 Mn
Sep 30, 2022 253.10 Mn
Jun 30, 2022 288.52 Mn
Mar 31, 2022 267.54 Mn
Dec 31, 2021 300.72 Mn
Sep 30, 2021 335.89 Mn